Caffeinated Beverage Intake, Dyspnea With Ticagrelor, and Cardiovascular Outcomes: Insights From the PEGASUS‐TIMI 54 Trial

BACKGROUND: A proposed cause of dyspnea induced by ticagrelor is an increase in adenosine blood levels. Because caffeine is an adenosine antagonist, it can potentially improve drug tolerability with regard to dyspnea. Furthermore, association between caffeine and cardiovascular events is of clinical...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Am Heart Assoc
Hlavní autoři: Furtado, Remo H. M., Venkateswaran, Ramkumar V., Nicolau, Jose C., Gurmu, Yared, Bhatt, Deepak L., Storey, Robert F., Steg, P. Gabriel, Magnani, Giuglia, Goto, Shinya, Dellborg, Mikael, Kamensky, Gabriel, Isaza, Daniel, Aylward, Philip, Johanson, Per, Bonaca, Marc P.
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2020
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7660882/
https://ncbi.nlm.nih.gov/pubmed/32410485
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.119.015785
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky